Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Stock Forecast

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for Pacira BioSciences stock ranges from a low of $10 to a high of $65. The average analyst price target of $29.89 forecasts a 27.30% increase in the stock price over the next year.

Price Target: $29.89 (+27.30%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$29.89	$25	$65
Change	-57.41%	+27.30%	+6.47%	+176.83%

* Price targets were last updated on May 9, 2025.

Analyst Ratings

The average analyst rating for Pacira BioSciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	3	3	3	3	3	3
Buy	3	3	3	3	3	3
Hold	3	2	2	2	2	2
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	10	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Strong Buy Maintains $32 → $30	Strong Buy	Maintains	$32 → $30	+27.77%	May 9, 2025
Serge Belanger Needham	Needham	Strong Buy Reiterates $32	Strong Buy	Reiterates	$32	+36.29%	Apr 8, 2025
Oren Livnat HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $48 → $65	Strong Buy	Maintains	$48 → $65	+176.83%	Apr 8, 2025
Balaji Prasad Barclays	Barclays	Buy Maintains $17 → $24	Buy	Maintains	$17 → $24	+2.21%	Feb 28, 2025
Serge Belanger Needham	Needham	Strong Buy Maintains $30 → $32	Strong Buy	Maintains	$30 → $32	+36.29%	Feb 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

753.84M

Increased by 7.54%

from 700.97M

Revenue Next Year

835.12M

Increased by 10.78%

from 753.84M

EPS This Year

2.81

from -2.15

EPS Next Year

3.35

Increased by 19.14%

from 2.81

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	429.65M	541.53M	666.82M	674.98M	700.97M	753.84M	835.12M	916.00M
Revenue Growth	2.05%	26.04%	23.14%	1.22%	3.85%	7.54%	10.78%	9.68%
EPS	3.33	0.92	0.34	0.89	-2.15	2.81	3.35	4.29
EPS Growth	-	-72.37%	-63.04%	160.68%	-	-	19.14%	28.05%
Forward PE	-	-	-	-	-	8.36	7.02	5.48
No. Analysts	-	-	-	-	-	9	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	792.7M	897.2M	995.8M
Avg	753.8M	835.1M	916.0M
Low	715.9M	787.2M	808.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	13.1%	19.0%	19.2%
Avg	7.5%	10.8%	9.7%
Low	2.1%	4.4%	-3.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	3.56	4.13	5.38
Avg	2.81	3.35	4.29
Low	2.05	2.99	3.37

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	47.1%	60.8%
Avg	-	19.1%	28.0%
Low	-	6.4%	0.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.